|
|
 |
|
Viewing report
|
|
|
|
Company Financials: Flamel Technologies
Datamonitor, Jan 2010
The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .
Scope
- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation
- Provides key ratios
- Includes information on revenue distribution by business segments and geographies
Highlights of this title
Flamel Technologies (Flamel) is a biopharmaceutical company principally engaged in the development of polymer-based delivery technologies for medical applications. Its Micropump technology is a controlled release and taste-masking technology for the oral administration of small molecule drugs.
Key reasons to purchase this title
- Includes information on revenue distribution by business segments and geographies
- Understand the financial evolution of the company over the last five years
- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization
Customers who bought this item also bought
Company Financials: Medtronic, Inc.
Company Financials: ImmunoGen, Inc.
Company Financials: Labopharm Inc.
Company Financials: Candela Corporation
Company Financials: DUSA Pharmaceuticals, Inc.
Company Financials: Momenta Pharmaceuticals
Company Financials: Alexza Pharmaceuticals
Company Financials: DURECT Corporation
Company Financials: Alkermes, Inc.
Company Financials: Becton, Dickinson and Company
|
|
|
|
